The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Psychedelic-assisted psychotherapy: Where is the psychotherapy research
Open accessAbstract
Rationale Psychedelic-assisted psychotherapy (PAP) has emerged as a potential treatment for a variety of mental health conditions, including substance use disorders and depression. Current models of PAP emphasize the importance of psychotherapeutic support before, during, and after ingestion of a psychedelic to maximize safety and clinical benefit. Despite this ubiquitous assumption, there has been surprisingly little empirical investigation of the "psychotherapy" in PAP, leaving critical questions about the necessary and sufficient components of PAP unanswered. Objectives As clinical trials for psychedelic compounds continue the transition from safety- and feasibility-testing to evaluating efficacy, the role of the accompanying psychotherapy must be better understood to enhance scientific understanding of the mechanisms underlying therapeutic change, optimize clinical outcomes, and inform cost-effectiveness. Results The present paper first reviews the current status of psychotherapy in the PAP literature, starting with recent debates regarding "psychotherapy" versus "psychological support" and then overviewing published clinical trial psychotherapy models and putative models informed by theory. We then delineate lessons that PAP researchers can leverage from traditional psychotherapy research regarding standardizing treatments (e.g., publish treatment manuals, establish eligibility criteria for providers), identifying mechanisms of change (e.g., measure established mechanism…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Psychedelic-assisted psychotherapy (PAP), a therapeutic approach augmenting talking therapy with psychedelic substances, has been recently classified as a potential breakthrough treatment for psychiatric illness (19).”
From Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol (2025) · cites this paper as [19]
Citations
Cites
On making causal claims: A review and recommendations
Antonakis, J., Bendahan, S., Jacquart, P., & Lalive, R. (2010) · The Leadership Quarterly · doi:10.1016/j.leaqua.2010.10.010 · Cited by 2,441 · cited 1×
“The primary advantage of CLPMs compared to traditional cross-sectional correlational analyses is accounting for temporality, a primary criterion for causal inference (Antonakis et al. 2010).”
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 2×
“The psychedelic peak therapy model includes a semi-structured approach to adjunctive psychotherapy, historically described as a “non-directive supportive” framework, in which therapists minimize verbal interactions with participants during the dosing experience (Griffiths et al. 2016).”
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Trial of Psilocybin versus Escitalopram for Depression
Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032994 · Cited by 1,391
Clinical psychology: Science and practice.
Kazdin, A. E. (1994) · Clinical Psychology: Science and Practice · doi:10.1111/j.1468-2850.1994.tb00001.x · Cited by 1,357
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3285 · Cited by 1,301 · cited 2×
“Nonetheless, the psyche-delic peak therapy model has been ubiquitously applied to modern PAP research—across various psychedelic drugs, research groups, and clinical diagnoses (Davis et al. 2021b; Johnson et al. 2014; Ross et al. 2016).”
Human hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203
REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics
Carhart-Harris, R. L., & Friston, K. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017160 · Cited by 1,180
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., Bird, C., Blom, R. E., Brennan, C., Brusch, D., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206443 · Cited by 1,167 · cited 1×
“Yet, the same researchers expressing skepticism of the necessity of psychotherapy in PAP recently published a phase 2 clinical trial (Goodwin et al. 2022) that included (a) trained “therapists” present at each stage of the study intervention, (b) an unpub-lished “therapist manual” guiding therapist…”
Research works printed but not linked: 6
- Grob CS, Grigsby J (2021) Handbook of Medical Hallucinogens. The Guilford
- Grof S (1980) LSD Psychotherapy. Hunter House
- Leary T (1966) Psychedelic prayers after the Tao Te Ching, vol 1. Poets
- Luborsky L, Rosenthal R, Diguer L, Andrusyna TP, Berman JS, Levitt JT, Seligman DA, Krause ED (2002) The dodo bird verdict is alive and well–mostly. Clin Psychol Sci Pract 9:2–12
- Morgan NL (2020) Integrating psychedelic experiences utilizing the internal family systems therapeutic model. Int J Social Sci Manage Rev 3:257–264
- Rose J, Raine-Smith H (2023) EMDR as a preparation and integration tool in psychedelic-assisted therapy: a collaborative case study. EMDR Therapy Quarterly
Cited by
Wolff, M., Evens, R., Mertens, L. J., Schmidt, C., Beck, J. L., Rutrecht, H. M., Cherniak, A. D., Gründer, G., & Jungaberle, H. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241249698 · Cited by 41
Addressing blinding in classic psychedelic studies with innovative active placebos
Aday, J. S., Simonsson, O., Schindler, E. A. D., & D’Souza, D. C. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf023 · Cited by 33
Self-citationKruger, D. J., Aday, J. S., Fields, C. W., Kolbman, N., Glynos, N. G., Barron, J., Herberholz, M., & Boehnke, K. F. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2024.0011 · Cited by 28
Self-citationMenon, V., Ramamurthy, P., Venu, S., & Andrade, C. (2024) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13778 · Cited by 28
Aday, J. S., McAfee, J., Conroy, D. A., Hosanagar, A., Tarnal, V., Weston, C. L., Scott, K., Horowitz, D., Geller, J. A., Harte, S. E., et al. (2025) · Frontiers in Pain Research · doi:10.3389/fpain.2025.1527783 · Cited by 27
Self-citation
Metadata
- Authors
- Aday, J. S., Horton, D., Fernandes-Osterhold, G., O’Donovan, A., Bradley, E. R., Rosen, R. C., & Woolley, J. D.
- Affiliations
- University of Michigan (US)
- University of Wisconsin–Madison (US)
- University of California, San Francisco (US)
- San Francisco VA Medical Center (US)
- Corresponding author
- Aday, Jacob S.
- Venue
- Psychopharmacology
- Published
- 2024-05-24
- Volume
- 241
- Issue
- 8
- Pages
- 1517-1526
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W4398774731
- Cited by
- 54
- References
- 87
- Citations by year
- 2026: 26 · 2025: 19 · 2024: 9
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PsyArXiv (OSF Preprints) (submittedVersion, cc-by)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007080)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psychedelic-assisted psychotherapy, psychotherapy models, psychological support, mechanisms of change, treatment standardization, substance use disorders, depression
- MeSH terms
- Mental Disorders, Hallucinogens, Humans, Psychotherapy, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psychedelic-assisted psychotherapy: Where is the psychotherapy research. https://app.cochat.ai/papers/10.1007/s00213-024-06620-x
- The paper
- Aday, J. S., Horton, D., Fernandes-Osterhold, G., O’Donovan, A., Bradley, E. R., Rosen, R. C., & Woolley, J. D. (2024). Psychedelic-assisted psychotherapy: Where is the psychotherapy research. Psychopharmacology. https://doi.org/10.1007/s00213-024-06620-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.